Novabutine Tablet 150 mg (Trimebutine Maleate)

Adult dose

Administer 100-200 mg of Trimebutine Maleate orally before meals, three times a day. Adjust dosage appropriately based on age and symptoms.

This medication contains lactose, so it should not be used by patients with specific genetic disorders that impair lactose digestion. Rarely, gastrointestinal-related symptoms such as constipation, diarrhea, abdominal discomfort, nausea, vomiting, digestive disturbances, dry mouth, and oral numbness may occur with the use of this medication. Infrequently, symptoms of rapid heartbeat may occur. Mental or neurological symptoms such as fatigue, drowsiness, dizziness, lethargy, and headache may also occur rarely. Caution is necessary as it may affect liver function, and rare cases of elevated liver enzyme levels may occur. Allergic reactions may present as skin rashes; if such symptoms occur, the use of the medication should be discontinued. The safety of this medication during pregnancy has not been sufficiently established; therefore, it should only be used by pregnant women or women who may become pregnant if the benefits of treatment are considered to outweigh the risks. The safety of this drug in breastfeeding women has also not been established, so it is advisable to avoid use if possible, and if necessary, to discontinue breastfeeding during treatment.

Mild side effects

• Constipation
• diarrhea
• abdominal fullness
• nausea
• vomiting
• digestive disturbances
• dry mouth
• oral numbness
• palpitations
• fatigue

This medication should be stored in a sealed container to prevent air or moisture exposure, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent deterioration.

Appearance

White round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle